Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 8 (MED8) is a protein component of the Mediator complex, a multi-subunit coactivator required for regulated transcription of nearly all RNA polymerase II-dependent genes. The Mediator complex acts as a molecular bridge, transmitting signals from sequence-specific transcriptional activators and repressors to RNA polymerase II and general transcription factors, facilitating assembly of the transcriptional preinitiation complex. MED8 is thought to participate in protein-protein interactions, serving as a structural hub; it can harbor domains with intrinsic disorder, important for engaging multiple partners. In plants, MED8 suppresses oxidative stress- and phytohormone-induced gene expression and interacts directly with transcriptional regulators involved in defense signaling and microRNA biogenesis. MED8 may also play a role in the recruitment of target proteins for ubiquitination and degradation, but this function is less well characterized in humans. While critical for basic gene expression, MED8 is not a typical "druggable" target as defined in pharmacology or clinical medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 8 (MED8).